CRON
Price
$3.14
Change
-$0.02 (-0.63%)
Updated
Sep 11 closing price
Capitalization
1.15B
60 days until earnings call
Intraday BUY SELL Signals
OGI
Price
$1.05
Change
-$0.02 (-1.87%)
Updated
Sep 11 closing price
Capitalization
150.36M
Intraday BUY SELL Signals
Interact to see
Advertisement

CRON vs OGI

CRON vs OGI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRON vs. OGI commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and OGI is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.15B) has a higher market cap than OGI($150M). CRON has higher P/E ratio than OGI: CRON (16.47) vs OGI (2.41). CRON YTD gains are higher at: 19.392 vs. OGI (-37.500). OGI has higher annual earnings (EBITDA): 18.4M vs. CRON (9.02M). CRON has more cash in the bank: 797M vs. OGI (11.7M). CRON has less debt than OGI: CRON (1.3M) vs OGI (31.5M). OGI has higher revenues than CRON: OGI (309M) vs CRON (179M).
CRONOGICRON / OGI
Capitalization1.15B150M769%
EBITDA9.02M18.4M49%
Gain YTD19.392-37.500-52%
P/E Ratio16.472.41683%
Revenue179M309M58%
Total Cash797M11.7M6,812%
Total Debt1.3M31.5M4%
FUNDAMENTALS RATINGS
CRON vs OGI: Fundamental Ratings
CRON
OGI
OUTLOOK RATING
1..100
8454
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8046
PRICE GROWTH RATING
1..100
4164
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/a47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (30) in the null industry is in the same range as CRON (46) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as CRON (100) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

OGI's SMR Rating (46) in the null industry is somewhat better than the same rating for CRON (80) in the Pharmaceuticals Other industry. This means that OGI’s stock grew somewhat faster than CRON’s over the last 12 months.

CRON's Price Growth Rating (41) in the Pharmaceuticals Other industry is in the same range as OGI (64) in the null industry. This means that CRON’s stock grew similarly to OGI’s over the last 12 months.

CRON's P/E Growth Rating (97) in the Pharmaceuticals Other industry is in the same range as OGI (100) in the null industry. This means that CRON’s stock grew similarly to OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONOGI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 18 days ago
73%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (CRON: $3.14 vs. OGI: $1.05)
Brand notoriety: CRON and OGI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRON: 54% vs. OGI: 62%
Market capitalization -- CRON: $1.15B vs. OGI: $150.36M
CRON [@Pharmaceuticals: Generic] is valued at $1.15B. OGI’s [@Pharmaceuticals: Generic] market capitalization is $150.36M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 0 FA rating(s) are green while OGI’s FA Score has 1 green FA rating(s).

  • CRON’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 1 green, 4 red.
According to our system of comparison, OGI is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 4 TA indicator(s) are bullish while OGI’s TA Score has 6 bullish TA indicator(s).

  • CRON’s TA Score: 4 bullish, 5 bearish.
  • OGI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OGI is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а -3.68% price change this week, while OGI (@Pharmaceuticals: Generic) price change was -9.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

Reported Earning Dates

CRON is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
CRON
Daily Signal:
Gain/Loss:
OGI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RFNBX101.360.50
+0.50%
American Funds Fundamental Invs R-2
AIORX12.680.06
+0.48%
American Century International Opps R
TFFCX79.02N/A
N/A
Touchstone Focused C
LAMSX26.80N/A
N/A
Lord Abbett Dividend Growth R4
LIFLX17.13N/A
N/A
Lord Abbett Focused Large Cap Value I

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-0.63%
SNDL - CRON
73%
Closely correlated
N/A
ACB - CRON
68%
Closely correlated
+0.27%
CGC - CRON
62%
Loosely correlated
-0.25%
TRLV - CRON
55%
Loosely correlated
-0.09%
GLAS - CRON
52%
Loosely correlated
-0.63%
More

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with ACB. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then ACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
-1.87%
ACB - OGI
69%
Closely correlated
+0.27%
SNDL - OGI
67%
Closely correlated
N/A
CGC - OGI
61%
Loosely correlated
-0.25%
CRON - OGI
51%
Loosely correlated
-0.63%
TRLV - OGI
49%
Loosely correlated
-0.09%
More